SLAQcProinALSCaregiversOffrir du soutien psychologique, technique et financier aux familles touchées par la SLA et…July 20th

Reminder: You have until Monday, July 23, to share your individual input regarding the impact of an ALS diagnosis, your experience with the limited treatments currently available as well as your expectations toward Radicava (Edaravone) by directly submitting your feedback to l'Institut national d’excellence en santé et en services sociaux (INESSS) https://www.ine…php?id=639&L=1

Please visit l’INESSS’ “Comment on a drug product” webpage to learn how to proceed:

To submit your individual input, please fill in this survey available on l'INESSS' website. The survey closes on July 23:

This helped 4 others